Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Secondary cytoreduction--thoughts on the "pro" side

L F Carson1, S C Rubin

  • 1Women's Cancer Center, Department of Obstetrics and Gynecology, Minneapolis, Minnesota 55455.

Gynecologic Oncology
|October 1, 1993
PubMed
Summary

Secondary cytoreduction surgery offers survival benefits for ovarian carcinoma patients in specific settings. However, evidence for improved outcomes is lacking when disease progresses during initial chemotherapy.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sutureless technique for cold-knife conization: a report of seventy-four consecutive cases.

Journal of lower genital tract disease·2015
Same author

Radiation therapy with concomitant and adjuvant cisplatin and paclitaxel in high-risk cervical cancer: long-term follow-up.

European journal of gynaecological oncology·2006
Same author

Efficacy and tolerability of lower-dose topotecan in recurrent ovarian cancer: a retrospective case review.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2005
Same author

Early ovarian cancer.

Current treatment options in oncology·2002
Same author

Using a belly board device to reduce the small bowel volume within pelvic radiation fields in women with postoperatively treated cervical carcinoma.

Gynecologic oncology·2001
Same author

The implementation of critical pathways in gynecologic oncology in a managed care setting: a cost analysis.

Gynecologic oncology·2001

Area of Science:

  • Gynecologic Oncology
  • Surgical Oncology
  • Clinical Cancer Research

Background:

  • Ovarian carcinoma treatment often involves primary surgery and chemotherapy.
  • Recurrent or persistent disease necessitates further therapeutic strategies.
  • Secondary cytoreduction is a debated approach in managing ovarian cancer.

Purpose of the Study:

  • To review the existing literature on secondary cytoreduction in ovarian carcinoma.
  • To identify clinical scenarios where secondary cytoreduction may offer benefits.
  • To evaluate the evidence supporting survival and quality of life improvements.

Main Methods:

  • Literature review of studies on secondary cytoreduction for ovarian cancer.
  • Categorization of patients into distinct clinical settings.
  • Analysis of data regarding survival and quality of life outcomes.

Main Results:

  • Positive outcomes (survival, quality of life) associated with debulking at second-look laparotomy, interval debulking, and post-recurrence debulking.
  • Limited or no evidence of survival or quality of life advantage for secondary debulking in cases of progressive disease during primary chemotherapy.

Conclusions:

  • Secondary cytoreduction can be advantageous in specific clinical settings for ovarian cancer.
  • The benefit of secondary cytoreduction is questionable when disease progresses on primary chemotherapy.
  • Further research is needed to clarify the role of secondary cytoreduction in advanced ovarian cancer.

Related Experiment Videos